Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice.

Abstract

Autologous hematopoietic stem cell transplantation (AHSCT) is approved for the treatment of select solid tumors, autoimmune disorders, and most hematologic malignancies. Multiple myeloma (MM) is the most common indication for AHSCT. Despite improvement in response and survival rates in the era of novel agents, AHSCT remains an important treatment option for… (More)
DOI: 10.1188/13.CJON.S2.13-24

Topics

7 Figures and Tables

Cite this paper

@article{Miceli2013AutologousHS, title={Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice.}, author={Teresa S Miceli and Kathryn E Lilleby and Kimberly Noonan and Sandra Kurtin and Beth Faiman and Patricia A Mangan}, journal={Clinical journal of oncology nursing}, year={2013}, volume={17 Suppl}, pages={13-24} }